Horizon Pharma plc Announces Michelle Parsons as a 2017 Healthcare Businesswomen's Association Luminary
May 11 2017 - 9:00AM
Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company
focused on improving patients' lives by identifying, developing,
acquiring and commercializing differentiated and accessible
medicines that address unmet medical needs, today announced
that Michelle Parsons, senior vice president, financial
planning and analysis, has been named a 2017 Healthcare
Businesswomen's Association (HBA) Luminary. Michelle
will be honored today at the 28th annual Woman of the Year
event in New York.
The HBA is the leading not-for-profit global organization
committed to furthering the advancement and impact of women in
healthcare worldwide. Michelle is being recognized for her
commitment to advancing other women's careers through mentoring and
sponsorship, as well as her 20-plus year dedication to the
healthcare industry.
"It is an honor to be named a luminary by the Healthcare
Businesswomen’s Association," said Michelle Parsons, senior vice
president, financial planning and analysis, Horizon Pharma
plc. "The growth and development of others is what I pride
myself on and during my career, I have always focused on helping
those around me reach their fullest potential. I'm humbled to
be a recipient of this award that honors passionate women in the
industry.”
Michelle joined Horizon Pharma in December 2014 as
vice president, financial planning and analysis and was promoted to
her current position in October 2015. During her long tenure
in the pharmaceutical industry, she has held numerous leadership
roles in financial systems, global planning and reporting.
Prior to joining Horizon Pharma, Michelle spent seven years
at Fenwal, Inc. where she was the vice president of finance,
responsible for directing her team in sales reporting, decision
support and business operations. She also held roles at Fenwal as a
director of global planning and reporting where she was responsible
for transitioning the global business and implementing global
systems, processes, and procedures. Prior to Fenwal, Michelle
spent 10 years at Dade Behring in several positions with
increasing responsibility in finance and global operations.
She received a bachelor's degree in accounting from
the Bloomsburg University of
Pennsylvania in Bloomsburg, Penn.
"Michelle has been instrumental in Horizon’s successes through
her exceptional work at the helm of the financial planning and
analysis team,” said Timothy P. Walbert, chairman, president
and chief executive officer, Horizon Pharma plc.
“Michelle’s outstanding leadership inspires those around her to
take their work to the next level and on behalf of all of her
colleagues, I congratulate Michelle on this important
recognition.”
About the Healthcare Businesswomen's
Association (HBA) The Healthcare Businesswomen's
Association (HBA) is a global not-for-profit organization
dedicated to furthering the advancement and impact of women in
healthcare worldwide. With 15 chapters throughout the US and
in Europe, HBA serves a community of over 30,000 individuals
and 100 Corporate Partners. The HBA provides networking
forums to build relationships; knowledge sharing and access to
thought leaders to broaden perspective; educational programs to
develop leadership skills and cutting edge industry knowledge and
recognition of outstanding women and companies to promote
visibility of their achievements.
About Horizon Pharma plcHorizon Pharma plc is a
biopharmaceutical company focused on improving patients' lives by
identifying, developing, acquiring and commercializing
differentiated and accessible medicines that address unmet medical
needs. The Company markets 11 medicines through its orphan,
rheumatology and primary care business units. For more
information, please visit www.horizonpharma.com. Follow
@HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
U.S. Media Contact:
Geoffrey Curtis
Senior Vice President, Corporate Affairs & Chief Communications Officer
media@horizonpharma.com
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Apr 2023 to Apr 2024